The Effects of Dry Needling Technique on Clinical Parameters of Patients With Migraine Headache: A Protocol for Randomized Clinical Trial
Abstract
Background: Migraine headache is one of the most common health complaints among adults. Myofascial trigger points in the cranial or cervical region may stimulate migraine symptoms and aggravate migraine pain. It seems that physiotherapy interventions such as trigger point dry needling could deactivate these points and may have positive effects on alleviating migraine symptoms. Therefore, this trial is proposed to investigate the impact of upper trapezius muscle dry needling in addition to drug therapy on headache characteristics in patients with migraine headaches.
Methods: A parallel randomized controlled trial with single-blinded outcome assessors will be conducted. Forty patients will be randomly assigned to two groups. The participants in the control group will receive drug therapy, and those in the intervention group will receive three sessions of trigger point dry needling of the upper trapezius muscle with an inter-session interval of one week as an additional treatment to drug therapy.
Outcomes and results: The primary outcome measure will be headache intensity measured by a daily headache diary form, and the secondary outcome measures will be the duration of headache, drug consumption, frequency of headache recorded by the daily headache diary form, pain pressure threshold, and pain intensity of the Myofascial trigger points in the upper trapezius muscle measured by an algometer and visual analog scale, respectively.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.